Mobile safe injecting facilities in Barcelona and Berlin

International Journal of Drug Policy

Volumn 23, Issue 4, 2012, Pages 257-260

  Dietze, Paul ^a,b   Winter, Rebecca ^a,b   Pedrana, Alisa ^a,b   Leicht, Astrid ^c   Majó i Roca, Xavier ^d   Brugal, M Teresa ^e  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Fixpunkt   (Germany)

^d GENERALITAT DE CATALUNYA   (Spain)

^e AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; TETANUS TOXOID;

COMMUNITY CARE; CONSULTATION; DRUG MARKETING; DRUG OVERDOSE; EDITORIAL; GERMANY; GOVERNMENT REGULATION; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH PERSONNEL ATTITUDE; HEPATITIS B; HUMAN; INJECTION; MOBILE SAFE INJECTING FACILITY; NURSING STAFF; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; SPAIN; TETANUS; VACCINATION;

GERMANY; HARM REDUCTION; HUMANS; MOBILE HEALTH UNITS; NEEDLE-EXCHANGE PROGRAMS; PUBLIC HEALTH; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84863839530     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.02.006     Document Type: Editorial

References (14)

1. Dettmer K., Saunders B., Strang J. Take home naloxone and the prevention of deaths from opiate overdose: Two pilot schemes. BMJ 2001, 322(7291):895-896.
2. Kimber J., Dolan K., van Beek I., Hedrich D., Zurhold H. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 2003, 22(2):227-233.
3. Kimber J., Dolan K., Wodak A. Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact. Drug and Alcohol Review 2005, 24(1):21-24.
4. Kimber J., Mattick R.P., Kaldor J., van Beek I., Gilmour S., Rance J.A. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug and Alcohol Review 2008, 1-11.
5. Moore D., Dietze P. Enabling environments and the reduction of drug-related harm: Re-framing Australian policy and practice. Drug and Alcohol Review 2005, 24(3):275-284.
6. MSIC Evaluation Committee Final report on the evaluation of the Sydney medically supervised injecting centre 2003, Authors, Sydney.
7. Needle R.H., Burrows D., Friedman S.R., Dorabjee J., Touze G., Badrieva L., et al. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. International Journal of Drug Policy 2005, 16(s1):s45-s57.
8. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M., et al. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction 2006, 101(10):1384-1393.
9. Salmon A.M., Thein H.H., Kimber J., Kaldor J.M., Maher L. Five years on: What are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?. International Journal of Drug Policy 2007, 18(1):46-53.
10. Sánchez-Niubò A., Domingo-Salvany A., Melis G.G., Brugal M.T., Scalia-Tomba G. Two methods to analyze trends in the incidence of heroin and cocaine use in Barcelona [Spain]. Gaceta Sanitaria 2007, 21:397-403.
11. Senatsverwaltung für Gesundheit U.u.V. Bericht über die Drogen- und Suchtsituation in Berlin 2008 2008, Author, Berlin.
12. Van Beek I., Kimber J., Dakin A., Gilmour S. The Sydney Medically Supervised Injecting Centre: Reducing harm associated with heroin overdose. Critical Public Health 2004, 14(4):391-406.
13. Wood E., Tyndall M.W., Lai C., Montaner J.S.G., Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Substance Abuse Treatment, Prevention, and Policy 2006, 1(13).
14. Wood E., Tyndall M.W., Montaner J.S., Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal 2006, 175(11):1399-1404.